INSIGHTS ON CLINICAL TRIAL PARTNERING

• When Sites Don't Get Paid

  Discover how Greenphire's innovative payment solutions can transform your clinical trial operations and ensure site sustainability.

• Help CROs Choose The Best Software: FDA Guidance On Umbrella Trials

  Utilize this guidance as a valuable resource in navigating the evolving landscape of clinical research in innovative and transformative fields.

• Preparing Data Packages For Regulatory Submission

  Gain insight into how a dermatology-specialized European CRO joined forces to carry out interim statistical analysis in its study on seven subjects and prepared necessary data packages for regulatory submission.

• Reimagining FSP With ProPharma's RCO Model

  Begin leveraging our Research Consulting Organization (RCO) model and gain access to customized, agile, and scalable solutions that continuously evolve to meet your unique needs.

• 5 Tactics For Sites To Improve On-Time Payments

  11/16/2023

  Review a collection of challenges and successful strategies for achieving timely payments shared by sites during a panel discussion at the SCRS Global Summit.

• Site Perspectives On BYOD ePRO Use

  6/17/2024

  This study examines participant convenience and compliance, aiming to understand and address the challenges faced by site personnel in global trials.

• Proof-Of-Concept Study Enabled To Drive Novel Gene Therapy Program

  9/29/2023

  Unearth how a natural history trial aimed at addressing the exceptionally rare neurological disease affecting pediatric patients with no existing treatment options was executed successfully.

• 4 Ways FSP Models Are Being Used To Drive Success

  9/11/2023

  Dive into several case studies where clients have leveraged clinical research services to surmount critical challenges within the industry and accelerate their achievements.

• Enhancing Site Capacity For Clinical Trials With DCT Nurses

  8/2/2024

  See how the rapid deployment of trained mobile nurses was able to mitigate resource-related obstacles and facilitate timely patient enrollment for a pediatric rare disease trial.